• Search History (Register)
  • MeSH Browser
  • [Clear]
    • English

Welcome to the international HTA database


Showing [16495 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2009     HAYES, Inc. Reclast (Novartis Pharmaceuticals Corp.) for bone loss prevention during breast cancer chemotherapy
2009     Health Services Assessment Collaboration (HSAC) What assessment tools are used both in New Zealand and in other countries for grading of evidence?
2009     National Institute for Health and Care Excellence (NICE) Percutaneous laser revascularisation for refractory angina pectoris. NICE interventional procedures guidance 302
2009     Belgian Health Care Knowledge Centre (KCE) The value of EEG and evoked potentials in clinical practice
2009     NIHR Health Technology Assessment programme Spinal cord stimulation for chronic pain of neuropathic or ischaemic origin: systematic review and economic evaluation
2009     HAYES, Inc. Acamprosate for alcoholism
2009     Technology Assessment Unit of the McGill University Health Centre (MUHC) Percutaneous radiofrequency ablation for treatment of hepatocellular carcinoma
2009     Health Services Assessment Collaboration (HSAC) Intestinal transplants: a rapid literature scan
2009     The Regional Health Technology Assessment Centre (HTA-centrum) Abdominal plastic surgery after massive weight reduction
2009     National Institute for Health and Care Excellence (NICE) Combined bony and soft tissue reconstruction for hip joint stabilisation in proximal focal femoral deficiency (PFFD). NICE interventional procedures guidance 297
2009     NIHR Health Technology Assessment programme The role of magnetic resonance imaging in the identification of suspected acoustic neuroma: a systematic review of clinical and cost effectiveness and natural history
2009     Institute for Clinical and Economic Review (ICER) Active surveillance and radical prostatectomy for clinically localized, low-risk prostate cancer
2009     Technology Assessment Unit of the McGill University Health Centre (MUHC) Clinical efficacy and cost of Allogenic Acellular Dermal Matrix (AADM) in implant-based breast reconstruction of post mastectomy cancer patients
2009     Health Services Assessment Collaboration (HSAC) Screening for the early detection of acoustic neuroma in patients with asymmetric sensorineural hearing loss: a rapid literature scan of MRI and other surveillance methods
2009     National Institute for Health and Care Excellence (NICE) Ex-vivo hepatic resection and reimplantation for liver cancer. NICE interventional procedures guidance 298
2009     NIHR Health Technology Assessment programme Dipsticks and diagnostic algorithms in urinary tract infection: development and validation, randomised trial, economic analysis, observational cohort, and qualitative study
2009     Technology Assessment Unit of the McGill University Health Centre (MUHC) Use of matrix coils in the treatment of cerebro-vascular aneurysms: an update
2009     National Institute for Health and Care Excellence (NICE) Endoscopic mastectomy and endoscopic wide local excision for breast cancer. NICE interventional procedures guidance 296
2009     Belgian Health Care Knowledge Centre (KCE) Tiotropium in the treatment of chronic obstructive pulmonary disease: health technology assessment
2009     NIHR Health Technology Assessment programme Systematic review of respite care in the frail elderly
2009     Technology Assessment Unit of the McGill University Health Centre (MUHC) Efficacy and cost-effectiveness of Collatamp-G for infection prophylaxis in cardiac surgery
2009     Health Services Assessment Collaboration (HSAC) Therapeutic models for mental injury as a result of sexual abuse: overview of the evidence from selected literature
2009     National Institute for Health and Care Excellence (NICE) Percutaneous (non-thoracoscopic) epicardial catheter radiofrequency ablation for atrial fibrillation. NICE interventional procedures guidance 294
2009     Institute of Applied Health Sciences (IAHS) Systematic review of the clinical effectiveness and cost-effectiveness of oesophageal Doppler monitoring in critically ill and high risk surgical patients
2009     NIHR Health Technology Assessment programme Neuroleptics in the treatment of aggressive challenging behaviour for people with intellectual disabilities: a randomised controlled trial (NACHBID)
2009     Technology Assessment Unit of the McGill University Health Centre (MUHC) The use of probiotics in the prevention and treatment of clostridium difficile diarrhea: an update
2009     HAYES, Inc. ResQPOD Impedance Threshold Device (ITD) (Advanced Circulatory Systems Inc.) for out-of-hospital cardiac arrest
2009     Health Services Assessment Collaboration (HSAC) The assessment and management of chronic pain in children and adolescents: an overview of selected literature.
2009     The Regional Health Technology Assessment Centre (HTA-centrum) [Treatment of early rheumatoid arthritis with a combination of TNF-alpha inhibitors and methotrexate, versus methotrexate alone]
2009     National Institute for Health and Care Excellence (NICE) Percutaneous (non-thoracoscopic) epicardial catheter radiofrequency ablation for ventricular tachycardia. NICE interventional procedures guidance 295
2009     NIHR Health Technology Assessment programme Diagnostic strategies using DNA testing for hereditary haemochromatosis in at-risk populations: a systematic review and economic evaluation
2009     Technology Assessment Unit of the McGill University Health Centre (MUHC) Transcatheter Aortic Valve Implantation (TAVI) at the MUHC: a Health Technology Assessment
2009     HAYES, Inc. Rituxan (rituximab) (Genentech Inc. and Biogen Idec Inc.) for rheumatoid arthritis refractory to methotrexate and/or tumor necrosis factor (TNF) inhibitors
2009     National Institute for Health and Care Excellence (NICE) Photodynamic therapy for brain tumours. NICE interventional procedures guidance 290
2009     NIHR Health Technology Assessment programme A randomised controlled trial to compare minimally invasive glucose monitoring devices to conventional monitoring in the management of insulin-treated diabetes mellitus (MITRE)
2009     Technology Assessment Unit of the McGill University Health Centre (MUHC) Radiofrequency ablation for treatment of Barrett's esophagus: A systematic review and cost analysis
2009     HAYES, Inc. VasoView HemoPro endoscopic vein harvesting system (Maquet Cardiovascular LLC) for coronary artery bypass graft (CABG)
2009     National Institute for Health and Care Excellence (NICE) Implantation of an opaque intraocular lens for intractable double vision. NICE interventional procedures guidance 293
2009     HAYES, Inc. Vivitrol (Injectable Naltrexone) (Alkermes Inc.) for outpatient treatment of alcohol dependence
2009     National Institute for Health and Care Excellence (NICE) Extracorporeal photopheresis for Crohn's disease. NICE interventional procedures guidance 288
2009     HAYES, Inc. Botulinum toxin treatment for essential tremor and spasticity for indications other than cerebral palsy and stroke
2009     National Institute for Health and Care Excellence (NICE) Intraocular lens insertion for correction of refractive error, with preservation of the natural lens. NICE interventional procedures guidance 289
2009     HAYES, Inc. High-Dose immunosuppressive therapy with or without hematopoietic transplantation for the treatment of rheumatic and mixed autoimmune diseases
2009     National Institute for Health and Care Excellence (NICE) Laparoscopic cystectomy. NICE interventional procedures guidance 287
2009     HAYES, Inc. Lung transplantation
2009     National Institute for Health and Care Excellence (NICE) Functional electrical stimulation for drop foot of central neurological origin. NICE interventional procedures guidance 278
2009     HAYES, Inc. Positron Emission Tomography (PET) for monitoring and prognosis of lung cancer
2009     National Institute for Health and Care Excellence (NICE) Ultrasound-guided regional nerve block. NICE interventional procedures guidance 285
2009     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Extracorporeal liver support of liver failure by means of Prometheus system]
2009     HAYES, Inc. Postoperative disposable ambulatory regional anesthesia
2009     Andalusian Health Technology Assessment Area (AETSA) [Helical tomotherapy. Current uses and utility]
2009     National Institute for Health and Care Excellence (NICE) Thoracoscopic epicardial radiofrequency ablation for atrial fibrillation. NICE interventional procedures guidance 286
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Long-acting Beta2-agonist and inhaled corticosteroid combination therapy for adult persistent asthma: systematic review of clinical outcomes and economic evaluation
2009     HAYES, Inc. Sodium hyaluronate for osteoarthritis
2009     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) Post-introduction observation of health technologies. A methodological guideline
2009     HAYES, Inc. Trigger point injections for myofascial pain
2009     Andalusian Health Technology Assessment Area (AETSA) [Endovascular treatment for thoracic aorta lesions]
2009     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) Identification, prioritisation and assessment of obsolete health technologies. A methodological guideline
2009     HAYES, Inc. Uterine artery embolization
2009     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) Strategies for the diffusion and dissemination of health technology assessment (HTA) products
2009     HAYES, Inc. Vagus nerve stimulation for depression
2009     HAYES, Inc. Vagus nerve stimulation for epilepsy
2009     NIHR Health Technology Assessment programme Systematic review and individual patient data meta-analysis of diagnosis of heart failure, with modelling of implications of different diagnostic strategies in primary care
2009     NIHR Health Technology Assessment programme Communication of carrier status information following universal newborn screening for sickle cell disorders and cystic fibrosis: qualitative study of experience and practice
2009     HAYES, Inc. Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy (ARVD/C)
2009     NIHR Health Technology Assessment programme How far does screening women for partner violence in different health care settings meet the UK National Screening Committee criteria for a screening programme in terms of condition, screening method and intervention?
2009     NIHR Health Technology Assessment programme Cessation of attention deficit hyperactivity disorder drugs in the young (CADDY) - a pharmacoepidemiological and qualitative study
2009     NIHR Health Technology Assessment programme Sensitivity analysis in economic evaluation: an audit of NICE current practice and a review of its use and value in decision-making
2009     HAYES, Inc. Ancillary urinary cytokeratin (CK) tests for bladder cancer screening and detection
2009     HAYES, Inc. BRCA1 and BRCA2 sequence variant analysis for susceptibility to hereditary ovarian cancer
2009     Health Council of the Netherlands Gezondheidsraad (GR) Proton radiotherapy
2009     HAYES, Inc. Ancillary urinary microsatellite analysis (MA) for bladder cancer screening and detection
2009     HAYES, Inc. ColoSure colorectal cancer detection test
2009     Health Council of the Netherlands Gezondheidsraad (GR) [The hospital as a healing environment]
2009     HAYES, Inc. deCODE ProstateCancer (deCODE diagnostics)
2009     Health Council of the Netherlands Gezondheidsraad (GR) Autism spectrum disorders: A lifetime of difference
2009     Technology Assessment at SickKids (TASK) Systematic review on orchidopexy for the Canadian Paediatric Surgical Wait Times project
2009     NIHR Health Technology Assessment programme The role of magnetic resonance imaging in the identification of suspected acoustic neuroma: systematic review of clinical and cost effectiveness, and natural history
2009     NIHR Health Technology Assessment programme Funding to cover the costs incurred to hold the 4th International Balliol Surgical Trials Colloquia
2009     HAYES, Inc. Late-onset familial alzheimer disease (AD2)
2009     Health Council of the Netherlands Gezondheidsraad (GR) General vaccination against hepatitis B revisited
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Topical diclofenac for the treatment of musculoskeletal pain unrelated to osteoarthritis: a review of the clinical effectiveness
2009     HAYES, Inc. Maturity-Onset Diabetes of the Young (MODY)
2009     Health Council of the Netherlands Gezondheidsraad (GR) [Pregnancy immunisation by red blood cells]
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Tiotropium for moderate-to-severe chronic obstructive pulmonary disease: a review of the clinical effectiveness and cost-effectiveness
2009     HAYES, Inc. MYH-Associated Polyposis (MAP)
2009     Health Council of the Netherlands Gezondheidsraad (GR) Care for the unborn child
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Sevelamer hydrochloride for the treatment of patients with chronic kidney disease: a review of the clinical effectiveness
2009     HAYES, Inc. PathFinderTG test for pancreatic cancer
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Pyxis and medDISPENSE automated medication dispensing systems: a review of the clinical benefits and harms, cost-effectiveness, and guidelines for use
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Portable bone mineral density scanners: a review of the clinical effectiveness
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Pharmacological management of depression in Parkinson's disease: evidence for antidepressant of choice
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Pharmacological interventions for weight loss: a review of the clinical and cost-effectiveness
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Oxybutynin, tolterodine, and darifenacin: review of cognitive adverse events
2009     NIHR Health Technology Assessment programme Telbivudine for the treatment of chronic hepatitis B infection
2009     Health Council of the Netherlands Gezondheidsraad (GR) A national colorectal cancer screening programme
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Octaplas compared to fresh frozen plasma to reduce the risk of transmitting lipid-enveloped viruses: supplementary analyses relating to risk of infection from an unknown virus
2009     NIHR Health Technology Assessment programme Entecavir for the treatment of chronic hepatitis B infection
2009     Belgian Health Care Knowledge Centre (KCE) Tiotropium in the treatment of chronic obstructive pulmonary disease health technology assessment
2009     Health Council of the Netherlands Gezondheidsraad (GR) Vaccination against pandemic influenza A/H1N1 2009: target groups and prioritisation